ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation
暂无分享,去创建一个
P. Ostano | E. Di Cicco | A. Samarkina | M. K. Youssef | Soumitra Ghosh | G. Dotto | Daniele Tavernari | Luigi Mazzeo | Jovan Isma | Christian Simon
[1] G. Domenici,et al. Tackling the tumor microenvironment – how can complex tumor models in vitro aid oncology drug development? , 2023, Expert opinion on drug discovery.
[2] G. Kollias,et al. Mesenchymal cells in health and disease , 2022, Nature Immunology.
[3] Andrew P. Bowman,et al. Sphingolipids control dermal fibroblast heterogeneity , 2022, Science.
[4] R. Kalluri,et al. Clinical and therapeutic relevance of cancer-associated fibroblasts , 2021, Nature Reviews Clinical Oncology.
[5] Oriol Vinyals,et al. Highly accurate protein structure prediction with AlphaFold , 2021, Nature.
[6] Hongmei Zhou,et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer , 2021, Signal Transduction and Targeted Therapy.
[7] G. Kollias,et al. Fibroblasts as immune regulators in infection, inflammation and cancer , 2021, Nature Reviews Immunology.
[8] B. Ludewig,et al. The AP-1 Transcription Factor Fosl-2 Regulates Autophagy in Cardiac Fibroblasts during Myocardial Fibrogenesis , 2021, International journal of molecular sciences.
[9] J. Campisi,et al. Cellular Senescence and the Senescence-Associated Secretory Phenotype as Drivers of Skin Photoaging. , 2020, The Journal of investigative dermatology.
[10] G. Dotto,et al. NOTCH1 gene amplification promotes expansion of Cancer Associated Fibroblast populations in human skin , 2020, Nature Communications.
[11] R. Langer,et al. Advances in oligonucleotide drug delivery , 2020, Nature Reviews Drug Discovery.
[12] J. Loyd,et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis , 2020, Science Advances.
[13] G. Ciriello,et al. Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis , 2020, bioRxiv.
[14] D. Tuveson,et al. DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS. , 2020, Physiological reviews.
[15] P. Mohler,et al. Advancing our understanding of AnkRD1 in cardiac development and disease. , 2020, Cardiovascular research.
[16] S. Werner,et al. A paracrine activin A–mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming , 2020, EMBO molecular medicine.
[17] Thea D. Tlsty,et al. A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.
[18] E. Guenova,et al. Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant , 2019, Cell reports.
[19] K. Zibara,et al. The AP-1 transcriptional complex: Local switch or remote command? , 2019, Biochimica et biophysica acta. Reviews on cancer.
[20] Qihao Ren,et al. Unmasking senescence: context-dependent effects of SASP in cancer , 2019, Nature Reviews Cancer.
[21] Melissa J. Davis,et al. Single sample scoring of molecular phenotypes , 2018, BMC Bioinformatics.
[22] Pedro Madrigal,et al. AP-1 Takes Centre Stage in Enhancer Chromatin Dynamics. , 2018, Trends in cell biology.
[23] S. Werner,et al. Nrf2-Mediated Fibroblast Reprogramming Drives Cellular Senescence by Targeting the Matrisome. , 2018, Developmental cell.
[24] C. Martins,et al. Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells , 2018, Nature Communications.
[25] Shawn M. Gillespie,et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.
[26] Kathleen M Jagodnik,et al. Massive mining of publicly available RNA-seq data from human and mouse , 2017, Nature Communications.
[27] Dong Eun Kim,et al. Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation , 2017, The Journal of experimental medicine.
[28] Yaoyong Li,et al. Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma , 2017, PLoS genetics.
[29] O. Liew,et al. Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential , 2017, International journal of molecular sciences.
[30] Irving L. Weissman,et al. Unifying mechanism for different fibrotic diseases , 2017, Proceedings of the National Academy of Sciences.
[31] D. Tuveson,et al. Br Ief Definitive Repor T , 2022 .
[32] R. Kalluri. The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.
[33] A. Bosio,et al. Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells. , 2016, Journal of visualized experiments : JoVE.
[34] Andrew D. Rouillard,et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins , 2016, Database J. Biol. Databases Curation.
[35] P. Gascard,et al. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy , 2016, Genes & development.
[36] Charles H. Yoon,et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.
[37] G C P van Zundert,et al. The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. , 2016, Journal of molecular biology.
[38] Antonio Rosato,et al. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth , 2015, Nature Cell Biology.
[39] Dong Eun Kim,et al. Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation , 2015, Nature Cell Biology.
[40] Nathan C. Sheffield,et al. ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors , 2015, Nature Methods.
[41] J. Reid,et al. A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer , 2015, BMC Cancer.
[42] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[43] R. Sanz-Pamplona,et al. Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information , 2014, Molecular oncology.
[44] M. Januszyk,et al. Tacrolimus fails to regulate collagen expression in dermal fibroblasts. , 2013, The Journal of surgical research.
[45] N. Elvassore,et al. A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors , 2013, Cell.
[46] A. Nicholson,et al. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease , 2013, Respiratory Research.
[47] Robert P. Jenkins,et al. Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts , 2013, Nature Cell Biology.
[48] Avi Ma'ayan,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[49] H. Soifer,et al. Antisense 2′-Deoxy, 2′-Fluoroarabino Nucleic Acid (2′F-ANA) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids , 2012, Molecular therapy. Nucleic acids.
[50] A. Reymond,et al. Multifocal Epithelial Tumors and Field Cancerization from Loss of Mesenchymal CSL Signaling , 2012, Cell.
[51] Aik Choon Tan,et al. Patient-derived tumour xenografts as models for oncology drug development , 2012, Nature Reviews Clinical Oncology.
[52] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[53] Clifford A. Meyer,et al. Cistrome: an integrative platform for transcriptional regulation studies , 2011, Genome Biology.
[54] Nikolina Radulovich,et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer , 2011, Proceedings of the National Academy of Sciences.
[55] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[56] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[57] N. Bourg,et al. A new pathway encompassing calpain 3 and its newly identified substrate cardiac ankyrin repeat protein is involved in the regulation of the nuclear factor‐κB pathway in skeletal muscle , 2010, The FEBS journal.
[58] C. Glass,et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.
[59] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[60] A. Rosenberg,et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy , 2008, Cancer biology & therapy.
[61] S. Hirono,et al. Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1 , 2008, Nature Biotechnology.
[62] G. T. Bowden,et al. UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. , 2004, Seminars in cancer biology.
[63] E. Wagner,et al. AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.
[64] M. Karin,et al. AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.
[65] R. Swerlick,et al. Identification and Characterization of a Novel Cytokine-inducible Nuclear Protein from Human Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.
[66] J. N. Mark Glover,et al. Crystal structure of the heterodimeric bZIP transcription factor c-Fos–c-Jun bound to DNA , 1995, Nature.
[67] OUP accepted manuscript , 2021, Nucleic Acids Research.
[68] J. Davidson,et al. Global deletion of Ankrd1 results in a wound-healing phenotype associated with dermal fibroblast dysfunction. , 2015, The American journal of pathology.